首页 > 最新文献

中华眼科杂志最新文献

英文 中文
[Efficacy of wound exclusion combined with silicone tube bicanalicular intubation in the treatment of pigmented nevi of the lacrimal punctum]. [伤口排除联合硅胶管双腔插管治疗泪小点色素痣的疗效]。
Q3 Medicine Pub Date : 2024-12-11 DOI: 10.3760/cma.j.cn112142-20240511-00219
J J He, J W Gong, J Jiang

Objective: To investigate the clinical efficacy of wound exclusion combined with silicone tube bicanalicular intubation for treatment of pigmented nevi of the lacrimal punctum. Methods: A retrospective case series analysis was conducted. Clinical data were collected from patients with pigmented nevi of the lacrimal punctum who underwent wound exclusion combined with silicone tube bicanalicular intubation at the Ophthalmology Center of Zhejiang Provincial People's Hospital from April 2020 to February 2023. During the surgery, a linear silicone tube was annularly placed to support the punctum and lacrimal canaliculus under local anesthesia, followed by the pigmented nevus excision under a surgical microscope. The linear silicone tube was removed at 4 to 6 weeks postoperatively. The duration of surgery and postoperative recovery status were recorded and summarized, including the recurrence of the pigmented nevus, epiphora, shape and position of the punctum, medial canthal morphology, and local scar condition. Results: This study included a total of 15 patients, 5 males and 10 females, with an average age of (47.7±13.5) years (range, 19 to 65 years). Two patients had pigmented nevi of the upper punctum, and 13 had pigmented nevi of the lower punctum. All nevi grew around the punctum and were completely excised during the surgery, which lasted (21.8±2.4) minutes on average. By 2 weeks postoperatively, all wounds healed with conjunctivalization, and new punctum openings formed. By 4 to 6 weeks postoperatively, the eyelid margin morphology was almost normal, when the linear silicone tube was removed. The follow-up ranged from 6 months to 2 years. No recurrence of the pigmented nevus was observed during the follow-up. The puncta were well formed without the symptom of epiphora, the medial canthal morphology was basically symmetrical to the healthy side, and the eyelid margin scars were inconspicuous, with a satisfactory appearance. No complications such as punctal occlusion, trichiasis, entropion, and ectropion occurred. Conclusions: For exophytic pigmented nevi of the punctum that do not deeply involve the lacrimal canaliculus, using the wound exclusion combined with silicone tube bicanalicular intubation during the nevus excision may reduce surgical trauma. This simple and feasible method can achieve good therapeutic effects and cosmetic outcomes.

目的探讨伤口排除联合硅胶管双腔插管治疗泪小点色素痣的临床疗效。方法:回顾性病例系列分析:进行回顾性病例系列分析。收集了2020年4月至2023年2月期间在浙江省人民医院眼科中心接受伤口排除联合硅胶管双腔插管术的泪小点色素痣患者的临床资料。手术中,在局麻下环形置入线性硅胶管支撑穿孔和泪道,然后在手术显微镜下切除色素痣。线性硅胶管在术后 4 至 6 周取出。记录并总结了手术时间和术后恢复情况,包括色素痣复发、外窥、穿孔形状和位置、泪道内侧形态和局部瘢痕情况。研究结果本研究共纳入 15 例患者,其中男性 5 例,女性 10 例,平均年龄(47.7±13.5)岁(19 至 65 岁)。2名患者的色素痣长在穿孔上部,13名患者的色素痣长在穿孔下部。所有的痣都长在穿刺点周围,并在手术中被完全切除,手术时间平均为(21.8±2.4)分钟。术后 2 周,所有伤口均愈合并结膜化,新的穿刺点开口形成。术后 4 至 6 周,移除线性硅胶管后,眼睑边缘形态基本正常。随访时间从 6 个月到 2 年不等。随访期间未发现色素痣复发。穿刺点形成良好,无眼睑外翻症状,内眼角形态与健侧基本对称,眼睑边缘疤痕不明显,外观令人满意。没有发生穿孔闭塞、倒睫、内翻和外翻等并发症。结论对于不深度累及泪小管的外生性点状色素痣,在痣切除术中使用伤口排除联合硅胶管双腔插管可减少手术创伤。这种简单可行的方法可以取得良好的治疗效果和美容效果。
{"title":"[Efficacy of wound exclusion combined with silicone tube bicanalicular intubation in the treatment of pigmented nevi of the lacrimal punctum].","authors":"J J He, J W Gong, J Jiang","doi":"10.3760/cma.j.cn112142-20240511-00219","DOIUrl":"https://doi.org/10.3760/cma.j.cn112142-20240511-00219","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the clinical efficacy of wound exclusion combined with silicone tube bicanalicular intubation for treatment of pigmented nevi of the lacrimal punctum. <b>Methods:</b> A retrospective case series analysis was conducted. Clinical data were collected from patients with pigmented nevi of the lacrimal punctum who underwent wound exclusion combined with silicone tube bicanalicular intubation at the Ophthalmology Center of Zhejiang Provincial People's Hospital from April 2020 to February 2023. During the surgery, a linear silicone tube was annularly placed to support the punctum and lacrimal canaliculus under local anesthesia, followed by the pigmented nevus excision under a surgical microscope. The linear silicone tube was removed at 4 to 6 weeks postoperatively. The duration of surgery and postoperative recovery status were recorded and summarized, including the recurrence of the pigmented nevus, epiphora, shape and position of the punctum, medial canthal morphology, and local scar condition. <b>Results:</b> This study included a total of 15 patients, 5 males and 10 females, with an average age of (47.7±13.5) years (range, 19 to 65 years). Two patients had pigmented nevi of the upper punctum, and 13 had pigmented nevi of the lower punctum. All nevi grew around the punctum and were completely excised during the surgery, which lasted (21.8±2.4) minutes on average. By 2 weeks postoperatively, all wounds healed with conjunctivalization, and new punctum openings formed. By 4 to 6 weeks postoperatively, the eyelid margin morphology was almost normal, when the linear silicone tube was removed. The follow-up ranged from 6 months to 2 years. No recurrence of the pigmented nevus was observed during the follow-up. The puncta were well formed without the symptom of epiphora, the medial canthal morphology was basically symmetrical to the healthy side, and the eyelid margin scars were inconspicuous, with a satisfactory appearance. No complications such as punctal occlusion, trichiasis, entropion, and ectropion occurred. <b>Conclusions:</b> For exophytic pigmented nevi of the punctum that do not deeply involve the lacrimal canaliculus, using the wound exclusion combined with silicone tube bicanalicular intubation during the nevus excision may reduce surgical trauma. This simple and feasible method can achieve good therapeutic effects and cosmetic outcomes.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 12","pages":"998-1003"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese expert consensus on the diagnosis and treatment of dry eye (2024)]. [中国干眼症诊治专家共识(2024)]。
Q3 Medicine Pub Date : 2024-12-11 DOI: 10.3760/cma.j.cn112142-20240517-00227

With the societal aging and the excessive use of video terminals, the prevalence rate of dry eye is increasing, and the causative factors are complex and diverse. Unremitting research and discussions on the diagnosis and treatment of dry eye have been carried out. An expert consensus on this issue was released in 2013. To further standardize and promote the diagnosis and treatment of dry eye, the Cornea Group of Chinese Ophthalmological Society and the Cornea Group of Ophthalmology Branch of Chinese Ophthalmologist Association have recently summarized the latest clinical findings and experience. A new version of the expert consensus has been formed to meet the needs of clinical practice.

随着社会老龄化和视频终端的过度使用,干眼症患病率不断上升,其病因复杂多样。人们对干眼症的诊断和治疗进行了不懈的研究和讨论。关于这个问题的专家共识于2013年发布。为进一步规范和促进干眼症的诊断和治疗,中国眼科学会角膜学组和中国眼科医师协会眼科分会角膜学组近期总结了干眼症的最新临床发现和经验。为适应临床实践的需要,形成了新版的专家共识。
{"title":"[Chinese expert consensus on the diagnosis and treatment of dry eye (2024)].","authors":"","doi":"10.3760/cma.j.cn112142-20240517-00227","DOIUrl":"10.3760/cma.j.cn112142-20240517-00227","url":null,"abstract":"<p><p>With the societal aging and the excessive use of video terminals, the prevalence rate of dry eye is increasing, and the causative factors are complex and diverse. Unremitting research and discussions on the diagnosis and treatment of dry eye have been carried out. An expert consensus on this issue was released in 2013. To further standardize and promote the diagnosis and treatment of dry eye, the Cornea Group of Chinese Ophthalmological Society and the Cornea Group of Ophthalmology Branch of Chinese Ophthalmologist Association have recently summarized the latest clinical findings and experience. A new version of the expert consensus has been formed to meet the needs of clinical practice.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 12","pages":"968-976"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of visual outcomes between corneal topography-guided FS-LASIK and SMILE for myopia and myopic astigmatism: a network meta-analysis]. [角膜地形图引导的FS-LASIK和SMILE治疗近视和近视散光视力结果的比较:网络荟萃分析]。
Q3 Medicine Pub Date : 2024-12-11 DOI: 10.3760/cma.j.cn112142-20240108-00014
Z Y Liu, Y G Chen
<p><p><b>Objective:</b> To compare the postoperative visual outcomes of corneal topography-guided femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) and small incision lenticule extraction (SMILE) for myopia and myopic astigmatism. <b>Methods:</b> Embase and PubMed were searched for randomized controlled trials (RCTs), prospective comparative studies, observational studies and retrospective studies of patients with myopia and/or myopic astigmatism treated by corneal topography-guided FS-LASIK, the other FS-LASIKs or SMILE (inception to November 2023). The studies meeting the criteria were collected and underwent quality assessment according to the Jadad scale for RCTs and the Newcastle-Ottawa scale for non-randomized studies. RevMan4.3.0 was used for network meta-analysis. <b>Results:</b> A total of 17 studies were included for meta-analysis, including 7 RCT and 10 observational studies. For the percentage of surgical eyes with uncorrected distance visual acuity≥20/20 (≤3 months), there were no statistically significant differences among corneal topography-guided FS-LASIK, the other FS-LASIKs and SMILE. The surface under the cumulative ranking curve (SUCRA) ranking from best to worst was corneal topography-guided FS-LASIK (86.7%), the other FS-LASIKs (53.1%) and SMILE (10.2%). For the percentage of surgical eyes with postoperative manifest refraction spherical equivalent (MRSE) within ±0.50 D (combined follow-up measure timepoint), the main analyses showed no statistical differences among the 3 surgery groups. The sensitivity analyses disclosed the relative risk (<i>RR</i>) of corneal topography-guided FS-LASIK significantly increased by 14% (<i>RR=</i>1.14, 95%<i>CI</i>:0.78-1.59) as compared to that of the other FS-LASIKs, while there was no significant difference between SMILE and the other FS-LASIKs. The SUCRA ranking from best to worst was corneal topography-guided FS-LASIK (90.4%), SMILE (31.7%) and the other FS-LASIKs (27.9%). For the percentage of surgical eyes with postoperative MRSE within± 1.00 D (combined follow-up measure timepoint), the main analyses showed no statistical differences among the 3 surgery groups. The sensitivity analyses showed the RR of corneal topography-guided FS-LASIK significantly increased by 15% (<i>RR=</i>1.15, 95%<i>CI</i>:0.93-1.61) as compared to that of the other FS-LASIKs, while there was no significant difference between SMILE and the other FS-LASIKs. The SUCRA ranking from best to worst was corneal topography-guided FS-LASIK (94.5%), the other FS-LASIKs (53.9%) and SMILE (1.7%). For the percentage of surgical eyes with postoperative corrected distance visual acuity improved by 1 or more lines (combined follow-up measure timepoint), the main analyses showed no statistical difference between corneal topography-guided FS-LASIK and the other FS-LASIKs, while the RR of SMILE was slightly lower than that of the other FS-LASIKs (<i>RR=</i>0.86, 95%<i>CI</i>:0.65-1.14). The sensitivity analyses
目的:比较角膜地形图引导飞秒激光辅助激光原位角膜磨晶状体手术(FS-LASIK)与小切口晶状体摘除(SMILE)治疗近视和近视散光的术后视力效果。方法:检索Embase和PubMed的随机对照试验(rct)、前瞻性比较研究、观察性研究和回顾性研究,这些研究涉及角膜地形图引导的FS-LASIK、其他FS-LASIK或SMILE治疗的近视和/或近视散光患者(启动至2023年11月)。收集符合标准的研究,并根据随机对照试验的Jadad量表和非随机研究的Newcastle-Ottawa量表进行质量评估。采用RevMan4.3.0进行网络meta分析。结果:共纳入17项研究进行meta分析,包括7项RCT研究和10项观察性研究。对于未矫正距离视力≥20/20(≤3个月)的手术眼百分比,角膜地形图引导的FS-LASIK与其他FS-LASIK和SMILE的差异无统计学意义。累积排名曲线下面(SUCRA)从好到坏依次为角膜地形引导FS-LASIK(86.7%)、其他FS-LASIK(53.1%)和SMILE(10.2%)。术后明显折射球当量(MRSE)在±0.50 D(联合随访测量时间点)内的手术眼百分比,主要分析3个手术组间无统计学差异。敏感性分析显示,角膜地形图引导的FS-LASIK相对危险度(RR)较其他FS-LASIK显著增加14% (RR=1.14, 95%CI:0.78-1.59), SMILE与其他FS-LASIK之间无显著差异。SUCRA评分从好到坏依次为角膜地形图引导的FS-LASIK(90.4%)、SMILE(31.7%)和其他FS-LASIK(27.9%)。术后MRSE在±1.00 D(联合随访测量时间点)内的手术眼百分比,主要分析显示3个手术组间无统计学差异。敏感性分析显示,角膜地形图引导的FS-LASIK与其他FS-LASIK相比,RR显著提高15% (RR=1.15, 95%CI:0.93-1.61), SMILE与其他FS-LASIK之间无显著差异。SUCRA评分从好到坏依次为角膜地形图引导的FS-LASIK(94.5%)、其他FS-LASIK(53.9%)和SMILE(1.7%)。对于术后矫正距离视力提高1线及以上的手术眼百分比(联合随访测量时间点),主要分析角膜地形图引导的FS-LASIK与其他FS-LASIK无统计学差异,SMILE的RR略低于其他FS-LASIK (RR=0.86, 95%CI:0.65 ~ 1.14)。敏感性分析显示,角膜地形图引导的FS-LASIK的RR较其他FS-LASIK显著提高40% (RR=1.40, 95%CI:0.06 ~ 24.00), SMILE的RR较其他FS-LASIK略低(RR=0.77, 95%CI:0.17 ~ 2.74)。SUCRA评分从好到坏依次为角膜地形图引导FS-LASIK(72.4%)、其他FS-LASIK(67.3%)和SMILE(10.3%)。结论:与SMILE相比,FS-LASIK术后视力改善相似。角膜地形图引导的FS-LASIK具有更好的可预测性,其MRSE率在±0.50 D/1.00 D范围内较高。
{"title":"[Comparison of visual outcomes between corneal topography-guided FS-LASIK and SMILE for myopia and myopic astigmatism: a network meta-analysis].","authors":"Z Y Liu, Y G Chen","doi":"10.3760/cma.j.cn112142-20240108-00014","DOIUrl":"10.3760/cma.j.cn112142-20240108-00014","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To compare the postoperative visual outcomes of corneal topography-guided femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) and small incision lenticule extraction (SMILE) for myopia and myopic astigmatism. &lt;b&gt;Methods:&lt;/b&gt; Embase and PubMed were searched for randomized controlled trials (RCTs), prospective comparative studies, observational studies and retrospective studies of patients with myopia and/or myopic astigmatism treated by corneal topography-guided FS-LASIK, the other FS-LASIKs or SMILE (inception to November 2023). The studies meeting the criteria were collected and underwent quality assessment according to the Jadad scale for RCTs and the Newcastle-Ottawa scale for non-randomized studies. RevMan4.3.0 was used for network meta-analysis. &lt;b&gt;Results:&lt;/b&gt; A total of 17 studies were included for meta-analysis, including 7 RCT and 10 observational studies. For the percentage of surgical eyes with uncorrected distance visual acuity≥20/20 (≤3 months), there were no statistically significant differences among corneal topography-guided FS-LASIK, the other FS-LASIKs and SMILE. The surface under the cumulative ranking curve (SUCRA) ranking from best to worst was corneal topography-guided FS-LASIK (86.7%), the other FS-LASIKs (53.1%) and SMILE (10.2%). For the percentage of surgical eyes with postoperative manifest refraction spherical equivalent (MRSE) within ±0.50 D (combined follow-up measure timepoint), the main analyses showed no statistical differences among the 3 surgery groups. The sensitivity analyses disclosed the relative risk (&lt;i&gt;RR&lt;/i&gt;) of corneal topography-guided FS-LASIK significantly increased by 14% (&lt;i&gt;RR=&lt;/i&gt;1.14, 95%&lt;i&gt;CI&lt;/i&gt;:0.78-1.59) as compared to that of the other FS-LASIKs, while there was no significant difference between SMILE and the other FS-LASIKs. The SUCRA ranking from best to worst was corneal topography-guided FS-LASIK (90.4%), SMILE (31.7%) and the other FS-LASIKs (27.9%). For the percentage of surgical eyes with postoperative MRSE within± 1.00 D (combined follow-up measure timepoint), the main analyses showed no statistical differences among the 3 surgery groups. The sensitivity analyses showed the RR of corneal topography-guided FS-LASIK significantly increased by 15% (&lt;i&gt;RR=&lt;/i&gt;1.15, 95%&lt;i&gt;CI&lt;/i&gt;:0.93-1.61) as compared to that of the other FS-LASIKs, while there was no significant difference between SMILE and the other FS-LASIKs. The SUCRA ranking from best to worst was corneal topography-guided FS-LASIK (94.5%), the other FS-LASIKs (53.9%) and SMILE (1.7%). For the percentage of surgical eyes with postoperative corrected distance visual acuity improved by 1 or more lines (combined follow-up measure timepoint), the main analyses showed no statistical difference between corneal topography-guided FS-LASIK and the other FS-LASIKs, while the RR of SMILE was slightly lower than that of the other FS-LASIKs (&lt;i&gt;RR=&lt;/i&gt;0.86, 95%&lt;i&gt;CI&lt;/i&gt;:0.65-1.14). The sensitivity analyses ","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 12","pages":"1004-1012"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Age as an important factor in the diagnosis and treatment of congenital cataract in children]. 【年龄是儿童先天性白内障诊治的重要因素】。
Q3 Medicine Pub Date : 2024-12-11 DOI: 10.3760/cma.j.cn112142-20240924-00418
Y Z Bao

The onset of congenital cataract is in the sensitive period of eyeball and visual development, and the pathogenic factors and clinical manifestations are diverse. The age of patients seeking medical treatment can range from the neonatal period to adolescence or even adulthood. However, minors are in continuous growth and development with various characteristics at different periods, which makes the diagnosis and treatment of congenital cataract complicated. In this article, the diagnosis and treatment strategies of congenital cataract are expounded according to the characteristics of the disease in infancy, early childhood, pre-school age and school age. It is pointed out that age is an important factor in the diagnosis and treatment of congenital cataract, which should be considered in related clinical work and scientific research.

先天性白内障的发病处于眼球和视力发育的敏感期,病因和临床表现多样。寻求治疗的患者年龄从新生儿期到青春期甚至成年期不等。然而,由于未成年人在不同时期处于不断生长发育的阶段,具有不同的特点,使得先天性白内障的诊断和治疗较为复杂。本文根据先天性白内障在婴儿期、幼儿期、学龄前和学龄期的特点,阐述了先天性白内障的诊断和治疗策略。指出年龄是影响先天性白内障诊治的重要因素,在相关临床工作和科学研究中应予以考虑。
{"title":"[Age as an important factor in the diagnosis and treatment of congenital cataract in children].","authors":"Y Z Bao","doi":"10.3760/cma.j.cn112142-20240924-00418","DOIUrl":"https://doi.org/10.3760/cma.j.cn112142-20240924-00418","url":null,"abstract":"<p><p>The onset of congenital cataract is in the sensitive period of eyeball and visual development, and the pathogenic factors and clinical manifestations are diverse. The age of patients seeking medical treatment can range from the neonatal period to adolescence or even adulthood. However, minors are in continuous growth and development with various characteristics at different periods, which makes the diagnosis and treatment of congenital cataract complicated. In this article, the diagnosis and treatment strategies of congenital cataract are expounded according to the characteristics of the disease in infancy, early childhood, pre-school age and school age. It is pointed out that age is an important factor in the diagnosis and treatment of congenital cataract, which should be considered in related clinical work and scientific research.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 12","pages":"964-967"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Reflection on the origin and pathogenesis of retinoblastoma]. [对视网膜母细胞瘤起源和发病机制的思考]。
Q3 Medicine Pub Date : 2024-11-11 DOI: 10.3760/cma.j.cn112142-20240724-00316
Z B Jin, J Xu, B Li

Retinoblastoma, one of the most common intraocular malignancies in infants and young children, seriously affects the vision and life. The in-depth study of the origin and pathogenesis of retinoblastoma, which remain controversial, is crucial. This article summarizes the research progress on the cell origin of retinoblastoma and the second hit theory, aiming to provide a theoretical basis for the diagnosis, treatment, and prevention of retinoblastoma.

视网膜母细胞瘤是婴幼儿最常见的眼内恶性肿瘤之一,严重影响视力和生命。视网膜母细胞瘤的起源和发病机制仍存在争议,深入研究视网膜母细胞瘤的起源和发病机制至关重要。本文总结了视网膜母细胞瘤细胞起源和二次打击理论的研究进展,旨在为视网膜母细胞瘤的诊断、治疗和预防提供理论依据。
{"title":"[Reflection on the origin and pathogenesis of retinoblastoma].","authors":"Z B Jin, J Xu, B Li","doi":"10.3760/cma.j.cn112142-20240724-00316","DOIUrl":"10.3760/cma.j.cn112142-20240724-00316","url":null,"abstract":"<p><p>Retinoblastoma, one of the most common intraocular malignancies in infants and young children, seriously affects the vision and life. The in-depth study of the origin and pathogenesis of retinoblastoma, which remain controversial, is crucial. This article summarizes the research progress on the cell origin of retinoblastoma and the second hit theory, aiming to provide a theoretical basis for the diagnosis, treatment, and prevention of retinoblastoma.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 11","pages":"883-886"},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on the pathogenesis of PM2.5 in ophthalmic diseases]. [眼科疾病中 PM2.5 致病机理的研究进展]。
Q3 Medicine Pub Date : 2024-11-11 DOI: 10.3760/cma.j.cn112142-20231220-00296
C C Yang, Y Ma, Q Jiang, J S Xue

PM2.5 is a fine particulate matter with an aerodynamic equivalent diameter of less than or equal to 2.5 μm, and it is the primary pollutant that causes haze. In recent years, numerous research results have shown that PM2.5 is associated with various ophthalmic diseases and its pathogenic mechanism is complex. It can disrupt the homeostasis of the tear film and the function of the meibomian glands, leading to dry eye; increase the risk of allergic and other types of conjunctivitis; may cause blepharitis; affect the homeostasis of the corneal epithelium and promote the development of keratopathy; the correlation with cataract is controversial; it is related to the risk of glaucoma; it is associated with age-related macular degeneration; it may also indirectly promote diabetic retinopathy. Prevention and control measures include controlling the level of PM2.5, strengthening publicity and screening, reducing going out and wearing goggles, etc. PM2.5 is closely related to ophthalmic diseases, but its specific pathogenic mechanism still requires more research to explore.

PM2.5 是一种空气动力学当量直径小于或等于 2.5 μm 的细颗粒物,是造成灰霾的主要污染物。近年来,大量研究结果表明,PM2.5 与多种眼科疾病相关,其致病机制复杂。它可以破坏泪膜的平衡和睑板腺的功能,导致干眼症;增加过敏性结膜炎和其他类型结膜炎的风险;可能引起睑缘炎;影响角膜上皮的平衡,促进角膜病变的发展;与白内障的相关性尚存争议;与青光眼的风险有关;与老年性黄斑变性有关;还可能间接促进糖尿病视网膜病变。防控措施包括控制PM2.5水平、加强宣传和筛查、减少外出和佩戴护目镜等。PM2.5与眼科疾病密切相关,但其具体的致病机制还需要更多的研究来探索。
{"title":"[Research progress on the pathogenesis of PM<sub>2.5</sub> in ophthalmic diseases].","authors":"C C Yang, Y Ma, Q Jiang, J S Xue","doi":"10.3760/cma.j.cn112142-20231220-00296","DOIUrl":"10.3760/cma.j.cn112142-20231220-00296","url":null,"abstract":"<p><p>PM<sub>2.5</sub> is a fine particulate matter with an aerodynamic equivalent diameter of less than or equal to 2.5 μm, and it is the primary pollutant that causes haze. In recent years, numerous research results have shown that PM<sub>2.5</sub> is associated with various ophthalmic diseases and its pathogenic mechanism is complex. It can disrupt the homeostasis of the tear film and the function of the meibomian glands, leading to dry eye; increase the risk of allergic and other types of conjunctivitis; may cause blepharitis; affect the homeostasis of the corneal epithelium and promote the development of keratopathy; the correlation with cataract is controversial; it is related to the risk of glaucoma; it is associated with age-related macular degeneration; it may also indirectly promote diabetic retinopathy. Prevention and control measures include controlling the level of PM<sub>2.5</sub>, strengthening publicity and screening, reducing going out and wearing goggles, etc. PM<sub>2.5</sub> is closely related to ophthalmic diseases, but its specific pathogenic mechanism still requires more research to explore.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 11","pages":"943-949"},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in the research of femtosecond laser-assisted lenticule intrastromal keratoplasty for the correction of hyperopia]. [飞秒激光辅助基质内角膜成形术矫正远视的研究进展]。
Q3 Medicine Pub Date : 2024-11-11 DOI: 10.3760/cma.j.cn112142-20240307-00100
S T Liu, X T Zhou

Lenticule intrastromal keratoplasty (LIKE) was introduced clinically in the 1980s as a refractive surgery. With the advancements of femtosecond laser, LIKE has been significantly revitalized. Currently, femtosecond laser-assisted LIKE has been demonstrated to be a safe and effective surgical procedure to correct hyperopia, but the predictability is still a major limitation. In this article, we review the history, procedures, influencing factors of predictability and challenge of LIKE to provide reference for clinical practice of femtosecond laser-assisted LIKE.

作为一种屈光手术,皮瓣基质内角膜成形术(LIKE)于 20 世纪 80 年代被引入临床。随着飞秒激光技术的发展,LIKE 又焕发了新的活力。目前,飞秒激光辅助 LIKE 已被证明是一种安全有效的矫正远视手术,但其可预测性仍是一大局限。本文回顾了飞秒激光辅助 LIKE 的发展历史、手术过程、可预测性的影响因素及面临的挑战,为飞秒激光辅助 LIKE 的临床实践提供参考。
{"title":"[Advances in the research of femtosecond laser-assisted lenticule intrastromal keratoplasty for the correction of hyperopia].","authors":"S T Liu, X T Zhou","doi":"10.3760/cma.j.cn112142-20240307-00100","DOIUrl":"10.3760/cma.j.cn112142-20240307-00100","url":null,"abstract":"<p><p>Lenticule intrastromal keratoplasty (LIKE) was introduced clinically in the 1980s as a refractive surgery. With the advancements of femtosecond laser, LIKE has been significantly revitalized. Currently, femtosecond laser-assisted LIKE has been demonstrated to be a safe and effective surgical procedure to correct hyperopia, but the predictability is still a major limitation. In this article, we review the history, procedures, influencing factors of predictability and challenge of LIKE to provide reference for clinical practice of femtosecond laser-assisted LIKE.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 11","pages":"950-958"},"PeriodicalIF":0.0,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese expert consensus on the prevention and treatment of complications of laser corneal refractive surgery (2024)]. [中国激光角膜屈光手术并发症防治专家共识(2024 年)]。
Q3 Medicine Pub Date : 2024-10-11 DOI: 10.3760/cma.j.cn112142-20240123-00041

Laser corneal refractive surgery has been carried out in China for three decades. The safety, efficacy, predictability, and long-term stability of the surgery have been well established. In the past 10 years, with the wide use of small incision lenticule extraction (SMILE) and trans-epithelial photorefractive keratectomy (T-PRK), the number of corneal laser surgeries in China has increased significantly. Although severe postoperative complications are rare, there is still the possibility of complications. Once complications occur and are not treated in time and effectively, the visual acuity and visual quality of patients would be affected. Paying attention to preoperative risk factors, standardization of the surgery procedure, and timely diagnosis and treatment of postoperative complications can minimize the negative effects. Therefore, the Cornea Group of Ophthalmology Branch of Chinese Medical Association has organized experts and scholars in this field to establish a consensus on the prevention and treatment of complications in laser corneal refractive surgery, providing guidance for the related clinical work.

激光角膜屈光手术在中国已经开展了三十年。该手术的安全性、有效性、可预测性和长期稳定性已得到充分肯定。近十年来,随着小切口皮瓣摘除术(SMILE)和经上皮光屈光性角膜切削术(T-PRK)的广泛应用,中国角膜激光手术的数量显著增加。虽然严重的术后并发症并不多见,但仍有发生并发症的可能。一旦出现并发症而得不到及时有效的治疗,患者的视力和视觉质量都会受到影响。关注术前风险因素,规范手术流程,及时诊治术后并发症,可以将负面影响降到最低。为此,中华医学会眼科学分会角膜病学组组织该领域的专家学者,就激光角膜屈光手术并发症的防治达成共识,为相关临床工作提供指导。
{"title":"[Chinese expert consensus on the prevention and treatment of complications of laser corneal refractive surgery (2024)].","authors":"","doi":"10.3760/cma.j.cn112142-20240123-00041","DOIUrl":"https://doi.org/10.3760/cma.j.cn112142-20240123-00041","url":null,"abstract":"<p><p>Laser corneal refractive surgery has been carried out in China for three decades. The safety, efficacy, predictability, and long-term stability of the surgery have been well established. In the past 10 years, with the wide use of small incision lenticule extraction (SMILE) and trans-epithelial photorefractive keratectomy (T-PRK), the number of corneal laser surgeries in China has increased significantly. Although severe postoperative complications are rare, there is still the possibility of complications. Once complications occur and are not treated in time and effectively, the visual acuity and visual quality of patients would be affected. Paying attention to preoperative risk factors, standardization of the surgery procedure, and timely diagnosis and treatment of postoperative complications can minimize the negative effects. Therefore, the Cornea Group of Ophthalmology Branch of Chinese Medical Association has organized experts and scholars in this field to establish a consensus on the prevention and treatment of complications in laser corneal refractive surgery, providing guidance for the related clinical work.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 10","pages":"804-812"},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Emerging challenges in the application of artificial intelligence for the eye disease screening in Chinese primary healthcare institutions]. [人工智能在中国基层医疗机构眼病筛查应用中的新挑战]。
Q3 Medicine Pub Date : 2024-10-11 DOI: 10.3760/cma.j.cn112142-20240623-00277
H D Zou, S L Lin, L N Lu, Y Xu

Breakthroughs have been achieved recently in the application of artificial intelligence (AI) for the eye disease screening in Chinese primary healthcare institutions, but challenges have also emerged. First, AI software has continuously evolved, expanding the range of eye diseases that can be screened, enhancing diagnostic accuracy, and progressing towards predicting the course of eye diseases. However, inadequate infrastructure such as 5G and a shortage of specialized personnel have hindered the coverage of screenings. Second, while the cost-effectiveness of AI is well-established, new screening models have impacted the equity of screenings. It is essential to tailor AI application models to the specific context of China. Third, AI screening guidelines have been increasingly improved, providing direction for AI development and reference for the promotion and application of AI technologies. Nonetheless, high-quality empirical research is urgently needed to provide scientific evidence for policymaking related to AI in the eye disease screening. Therefore, it is suggested to develop multimodal AI models that integrate basic data such as symptoms and medical history with simple ophthalmic examinations, to accelerate the construction of infrastructure like 5G and focus on cultivating interdisciplinary talents, to explore suitable service systems and models for the large-scale eye disease screening tailored to local conditions, and to conduct long-term, multi-center, empirical studies.

近年来,人工智能(AI)在中国基层医疗机构眼病筛查中的应用取得了突破性进展,但挑战也随之而来。首先,人工智能软件不断发展,可筛查的眼病范围不断扩大,诊断准确率不断提高,并朝着预测眼病病程的方向发展。然而,5G 等基础设施的不足和专业人员的短缺阻碍了筛查的覆盖面。其次,虽然人工智能的成本效益已得到公认,但新的筛查模式影响了筛查的公平性。必须根据中国的具体情况调整人工智能应用模式。第三,人工智能筛查指南日益完善,为人工智能发展指明了方向,也为人工智能技术的推广应用提供了参考。然而,眼病筛查中的人工智能相关政策制定亟需高质量的实证研究提供科学依据。因此,建议开发将症状、病史等基础数据与简单眼科检查相结合的多模态人工智能模型,加快5G等基础设施建设,注重培养跨学科人才,因地制宜探索适合大规模眼病筛查的服务体系和模式,开展长期、多中心的实证研究。
{"title":"[Emerging challenges in the application of artificial intelligence for the eye disease screening in Chinese primary healthcare institutions].","authors":"H D Zou, S L Lin, L N Lu, Y Xu","doi":"10.3760/cma.j.cn112142-20240623-00277","DOIUrl":"https://doi.org/10.3760/cma.j.cn112142-20240623-00277","url":null,"abstract":"<p><p>Breakthroughs have been achieved recently in the application of artificial intelligence (AI) for the eye disease screening in Chinese primary healthcare institutions, but challenges have also emerged. First, AI software has continuously evolved, expanding the range of eye diseases that can be screened, enhancing diagnostic accuracy, and progressing towards predicting the course of eye diseases. However, inadequate infrastructure such as 5G and a shortage of specialized personnel have hindered the coverage of screenings. Second, while the cost-effectiveness of AI is well-established, new screening models have impacted the equity of screenings. It is essential to tailor AI application models to the specific context of China. Third, AI screening guidelines have been increasingly improved, providing direction for AI development and reference for the promotion and application of AI technologies. Nonetheless, high-quality empirical research is urgently needed to provide scientific evidence for policymaking related to AI in the eye disease screening. Therefore, it is suggested to develop multimodal AI models that integrate basic data such as symptoms and medical history with simple ophthalmic examinations, to accelerate the construction of infrastructure like 5G and focus on cultivating interdisciplinary talents, to explore suitable service systems and models for the large-scale eye disease screening tailored to local conditions, and to conduct long-term, multi-center, empirical studies.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 10","pages":"799-803"},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The status and changing trend in the burden of refractive errors in China from 1990 to 2019]. [1990-2019年中国屈光不正负担现状及变化趋势]。
Q3 Medicine Pub Date : 2024-10-11 DOI: 10.3760/cma.j.cn112142-20231025-00186
J X Guo, H P Yin, Z R Guo, J H Chen, P P Liu, J F Wu, H S Bi

Objective: To comprehend the status and changing trend in the burden of refractive errors in China from 1990 to 2019, and to furnish data-driven support for the formulation of rational strategies in refractive error prevention and control. Methods: Using the Global Burden of Disease Database 2019, data on refractive error prevalence and years lived with disability (YLD) in China from 1990 to 2019 were extracted and their standardized rates were calculated. The trend of refractive error prevalence, age, period, and gender was analyzed using joinpoint regression models. Results: From 1990 to 2019, the number of cases, prevalence rate, and YLD rate of refractive errors in China showed an upward trend, which was consistent with global trends. However, the magnitude of the increase in these parameters was higher than the global average. Conversely, the age-standardized prevalence rate and age-standardized YLD rate demonstrated a declining trend, which was also consistent with global trends, but the reduction rate was less pronounced compared to global levels. Notably, all indicators for females, including prevalence and YLD, exceeded those of males. The prevalence and YLD rates of refractive errors in China increased with age. The older individuals had higher rates compared to younger individuals. In 1990, the highest prevalence and YLD rates were found in the ≥70 years group, while the lowest rates were in the <5 years group. The age group with the most substantial increase in the burden of refractive errors was the 15 to 49 years population, which remained consistent during the three decades. The joinpoint regression analysis results revealed a stage-wise fluctuation in the age-standardized prevalence and YLD rates of refractive errors in China from 1990 to 2019. Specifically, the age-standardized prevalence rate increased by 0.765% from 1990 to 2001, decreased by 0.963% from 2001 to 2014, increased by 4.214% from 2014 to 2017, and decreased by 3.029% from 2017 to 2019. In contrast, the age-standardized YLD rate decreased by 0.113% from 1990 to 1995, increased by 2.252% from 1995 to 2000, decreased by 1.102% from 2000 to 2014, increased by 4.326% from 2014 to 2017, and decreased by 5.090% from 2017 to 2019. Conclusions: The standardized prevalence of refractive errors and the standardized YLD rate in China showed a downward trend, which was less than the global average level, but the disease burden was still heavy. Gender and age emerged as significant influencing factors for the prevalence of refractive errors and YLD. It is imperative to enhance efforts in the prevention and treatment of refractive errors among the middle-aged and elderly population. Attention should also be directed towards the increasing burden in the<50 years population.

目的了解 1990 年至 2019 年中国屈光不正负担的现状和变化趋势,为制定合理的屈光不正防控策略提供数据支持。研究方法利用全球疾病负担数据库(Global Burden of Disease Database 2019),提取中国1990-2019年屈光不正患病率和残疾生活年数(YLD)数据,并计算其标准化比率。利用连接点回归模型分析了屈光不正患病率、年龄、时期和性别的变化趋势。结果从 1990 年到 2019 年,中国屈光不正的病例数、患病率和 YLD 率均呈上升趋势,这与全球趋势一致。但是,这些参数的增长幅度高于全球平均水平。相反,年龄标准化患病率和年龄标准化YLD率呈下降趋势,这也与全球趋势一致,但与全球水平相比下降幅度较小。值得注意的是,女性的所有指标,包括流行率和 YLD,都超过了男性。中国屈光不正的患病率和YLD率随年龄增长而增加。与年轻人相比,老年人的发病率更高。1990 年,≥70 岁组的患病率和 YLD 率最高,结论组最低:中国屈光不正的标准化患病率和标准化 YLD 率呈下降趋势,低于全球平均水平,但疾病负担仍然较重。性别和年龄是屈光不正和青光眼患病率的重要影响因素。加强中老年人屈光不正的预防和治疗工作势在必行。此外,还应关注中老年人群日益加重的屈光不正负担。
{"title":"[The status and changing trend in the burden of refractive errors in China from 1990 to 2019].","authors":"J X Guo, H P Yin, Z R Guo, J H Chen, P P Liu, J F Wu, H S Bi","doi":"10.3760/cma.j.cn112142-20231025-00186","DOIUrl":"https://doi.org/10.3760/cma.j.cn112142-20231025-00186","url":null,"abstract":"<p><p><b>Objective:</b> To comprehend the status and changing trend in the burden of refractive errors in China from 1990 to 2019, and to furnish data-driven support for the formulation of rational strategies in refractive error prevention and control. <b>Methods:</b> Using the Global Burden of Disease Database 2019, data on refractive error prevalence and years lived with disability (YLD) in China from 1990 to 2019 were extracted and their standardized rates were calculated. The trend of refractive error prevalence, age, period, and gender was analyzed using joinpoint regression models. <b>Results:</b> From 1990 to 2019, the number of cases, prevalence rate, and YLD rate of refractive errors in China showed an upward trend, which was consistent with global trends. However, the magnitude of the increase in these parameters was higher than the global average. Conversely, the age-standardized prevalence rate and age-standardized YLD rate demonstrated a declining trend, which was also consistent with global trends, but the reduction rate was less pronounced compared to global levels. Notably, all indicators for females, including prevalence and YLD, exceeded those of males. The prevalence and YLD rates of refractive errors in China increased with age. The older individuals had higher rates compared to younger individuals. In 1990, the highest prevalence and YLD rates were found in the ≥70 years group, while the lowest rates were in the <5 years group. The age group with the most substantial increase in the burden of refractive errors was the 15 to 49 years population, which remained consistent during the three decades. The joinpoint regression analysis results revealed a stage-wise fluctuation in the age-standardized prevalence and YLD rates of refractive errors in China from 1990 to 2019. Specifically, the age-standardized prevalence rate increased by 0.765% from 1990 to 2001, decreased by 0.963% from 2001 to 2014, increased by 4.214% from 2014 to 2017, and decreased by 3.029% from 2017 to 2019. In contrast, the age-standardized YLD rate decreased by 0.113% from 1990 to 1995, increased by 2.252% from 1995 to 2000, decreased by 1.102% from 2000 to 2014, increased by 4.326% from 2014 to 2017, and decreased by 5.090% from 2017 to 2019. <b>Conclusions:</b> The standardized prevalence of refractive errors and the standardized YLD rate in China showed a downward trend, which was less than the global average level, but the disease burden was still heavy. Gender and age emerged as significant influencing factors for the prevalence of refractive errors and YLD. It is imperative to enhance efforts in the prevention and treatment of refractive errors among the middle-aged and elderly population. Attention should also be directed towards the increasing burden in the<50 years population.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 10","pages":"822-831"},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华眼科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1